Letter to the Editor| Volume 23, ISSUE 4, P269, July 2001

Guidelines for reporting clinical features in cases with MECP2 mutations, by Alison Kerr and an international group

      Discovery of the causative gene of a certain disease clarifies its phenotypic heterogeneity. An unknown disease presenting with a distinct clinical and neurophysiological phenotype is often found to be caused by a mutation of the same gene for a genetically established disease. Thus, detection of a gene responsible for a variety of clinical phenotypes has an impact not only for investigating pathophysiology of a group of diseases but also for demonstrating common neural characteristics that had not been revealed by conventional neuropathological, biochemical or neurophysiological studies. Rett syndrome is not an exception. We should not miss a good opportunity at this stage.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Brain and Development
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect